# Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer

> **NCT00039676** · — · ACTIVE_NOT_RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 1836 (actual)

## Conditions studied

- Waldenstrom Macroglobulinemia
- Chronic Lymphocytic Leukemia
- Hodgkin Disease
- NonHodgkin Lymphoma
- Mixed Lymphoproliferative Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00039676
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2002-07-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 1836 (ACTUAL)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00039676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00039676, "Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00039676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*